AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

CMND · NASDAQ · Biotechnology

Clearmind Medicine (CMND)

Develops non-hallucinogenic MEAI treatments for alcohol use disorder and related conditions.

$1.75

Pre-market−0.11 (−6.11%)

At close$1.86(+1.64%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

	Institutions4 holders · as of Mar 31, 2026	1,138.28%	4.5K ADS
	Adds to	1,138.28%

395 ADS (1 ADS = 40 ordinary shares) as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (395 in the company's Sep 3, 2026 report, 1.49M elsewhere); stakes use the report.

These groups come from separate filings that can overlap, so they add to 1,138.28%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
XTX Topco LtdInstitution	549.22%	21,694 ADS	13Fas of Mar 31, 2026
HRT Financial LPInstitution	402.78%	15,910 ADS	13Fas of Mar 31, 2026
Advisorshares Investments LLCInstitution	186.25%	7,357 ADS	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.03%	1 ADS	13Fas of Mar 31, 2026
AdvisorShares TrustInstitution	—5.48% of class, as filed	—	13Gfiled Feb 14, 2024 ↗
Daniel B. AsherInsider	—6.30% of class, as filed	—	13Gfiled Apr 14, 2023 ↗
Eli PolatovInsider	—7.70% of class, as filed	—	13Gfiled Oct 26, 2023 ↗
Iroquois Capital Management, LLCStrategic	—8.10% of class, as filed	—	13Gfiled Feb 17, 2026 ↗
Ltd.Strategic	—9.33% of class, as filed	—	13Gfiled Dec 13, 2022 ↗
Medigus Ltd.Strategic	—5.77% of class, as filed	—	13Gfiled Feb 9, 2023 ↗
David Lamadrid¹Insiderdirector, 10 percent owner, officer: CEO and President	0.01%	1 ordinary	Form 4filed May 5, 2017 ↗

Last filed May 5, 2017; leaving the company requires no filing. Not in the bar.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

4 holders · 45.0K shares · 3 new positions · 4 increased · 0 reduced · 1 closed

Holder	Shares	% outstanding	Chg q/q	Filed
XTX Topco Ltd	21.7K	5,492.15%	+21.7Knew	May 15, 2026
HRT Financial LP	15.9K	4,027.85%	+15.9Knew	May 14, 2026
Advisorshares Investments LLC	7.4K	1,862.53%	+725	Apr 28, 2026
UBS Group AG	1	0.25%	+1new	May 5, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Iroquois Capital Management, LLC	8.10%		13G	Feb 17, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Jun 16, 2026	HRT Financial LP10 percent owner	Sale	22,139	$3.31	81,353
Jun 15, 2026	HRT Financial LP10 percent owner	Sale	3,183	$3.32	103,492
Jun 12, 2026	HRT Financial LP10 percent owner	Sale	2,102	$3.36	106,675
Jun 11, 2026	HRT Financial LP10 percent owner	Sale	225,191	$0.1230	1,838,075
Jun 10, 2026	HRT Financial LP10 percent owner	Purchase	2,159,052	$0.1530	2,063,266

CongressHouse and Senate disclosures

Not reported.